SAMSUNG PHARM. Co., LTD. Market Cap

SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 128.38 billion as of December 5, 2025. Its market cap has decreased by -13.23% in one year.

Market Cap

128.38B

Enterprise Value

n/a

Revenue

44.29B

Ranking

n/a

PE Ratio

10.10

Stock Price

1,364.00

Market Cap Chart

Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 128.38B, an increase of 617.82%. That is a compound annual growth rate of 6.72%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	128.38B	-11.31%
Dec 30, 2024	144.76B	-0.84%
Dec 28, 2023	145.99B	-18.99%
Dec 29, 2022	180.22B	-45.48%
Dec 30, 2021	330.57B	-11.17%
Dec 30, 2020	372.12B	50.47%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	77.77T
Celltrion	39.95T
ALTEOGEN	27.76T
ABL Bio	11.08T
SK Biopharmaceuticals	10.61T
Yuhan	8,911.91B
LigaChem Biosciences	7,139.05B
Peptron	6,540.52B

Market Cap Rankings